Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Merit Cudkowicz, M.D., MSc
NeuroClinical Trials Unit (Massachusetts General Hospital)
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Ucla, Dept. of Neurology - Neuromuscular/als Research Center
Los Angeles, California, United States
- the Forbes Norris Mda/als Research Center
San Francisco, California, United States
- University of Miami Miller School of Medicine
Miami, Florida, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
- Massachusettes General Hospital
Boston, Massachusetts, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Bryan Lgh Medical Center East
Lincoln, Nebraska, United States
- Columbia University, Lou Gehrig Mda/als Research Center
New York, New York, United States
- Suny Upstate Medical University
Syracuse, New York, United States
- Penn State Hershey Medical Center
Hershey, Pennsylvania, United States
- Drexel University College of Medicine
Philadelphia, Pennsylvania, United States
- University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- University of Texas Health Sciences Center of San Antonio
San Antonio, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- University of Virginia Health System
Charlottesville, Virginia, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2009
- Primary completion
- 31 Jul 2013
- Completion
- 31 Jul 2013
- Last update posted
- 16 Aug 2021
- Registered enrollment
- 74
- Registry id
- NCT00931944
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.